Main Sequence Ventures

Founded 2017
Founders Bill Bartee Martin Duursma Mike Nicholls Mike Zimmerman Phil Morle


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 33
Average round size
The average size of a deal this fund participated in
Portfolio companies 22
Rounds per year 8.25
Lead investments 17
Follow on index
How often the fund supports its portfolio startups at next rounds
Key employees 5
Stages of investment
Early Stage Venture

Areas of investment

  • Software
  • Internet of Things
  • Artificial Intelligence
  • Analytics
  • Machine Learning

Main Sequence Ventures is the famous VC, which was founded in 2017. The venture was found in Australia. The main department of described VC is located in the Sydney.

Among the most successful fund investment fields, there are Artificial Intelligence, Information Services. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Lumachain, Maxwell Plus, Intersective. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Australia. The fund has specific favorite in a number of founders of portfolio startups.

The fund is generally included in 7-12 deals every year. The common things for fund are deals in the range of 5 - 10 millions dollars. Speaking about the real fund results, this VC is 65 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2019.

This organization was formed by Bill Bartee, Martin Duursma, Mike Nicholls, Mike Zimmerman, Phil Morle.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Main Sequence Ventures, startups are often financed by Blackbird Ventures (Australia), muru-D, RCL Accelerator. The meaningful sponsors for the fund in investment in the same round are Blackbird Ventures (Australia), Horizons Ventures, muru-D. In the next rounds fund is usually obtained by muru-D, Uniseed Ventures, Square Peg Capital.

Read more

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Quantum Brilliance

Cloud Computing
Quantum Computing
$9M26 Aug 2021 Canberra, Australian Capital Territory, Australia

Regrow Ag

Machine Learning
$17M17 Aug 2021 New Hampshire, United States


Food and Beverage
Food Processing
$52M06 Aug 2021 Sydney, New South Wales, Australia

MGA Thermal

Energy Efficiency
Environmental Engineering
Renewable Energy
$5M03 Aug 2021 Newcastle, New South Wales, Australia

Gilmour Space Technologies

Industrial Engineering
Space Travel
$44M29 Jun 2021 Gold Coast, Queensland, Australia


3D Technology
Autonomous Vehicles
$29M24 Mar 2021 Sydney, New South Wales, Australia


Health Care
$6M07 Dec 2020 Australia, Queensland

Morse Micro

Internet of Things
$13M24 Nov 2020 Sydney, New South Wales, Australia


Food and Beverage
Food Processing
$56M20 Oct 2020 Sydney, New South Wales, Australia
Prospection Secures $45 million to Accelerate Growth of its Powerful Healthcare Insights Technology

– Prospection has successfully raised $45m from institutional investors in a Series B round, cornerstoned by new investor Ellerston JAADE with participation from existing shareholders Main Sequence and Horizons Ventures.
– Prospection uses real world data, powering evidence to deliver better patient outcomes. Its powerful AI algorithms follow millions of de-identified patients over time to search for patterns in their health and treatment journey. Uniquely, these algorithms can ingest multiple longitudinal patient and commercial datasets globally from varied sources such as governments, insurers, healthcare providers/institutions and health records, to produce rich and accurate insights at high speed.
– These datasets are turned into actionable, medical insights to help determine the best treatment plan for a patient, locate patients who would benefit from improved therapeutic decisions and be written into publishable evidence for scientific journals.

Quantum Brilliance Raises $9.7M in Seed Funding

– Quantum Brilliance is a full-stack quantum accelerator startup based in Canberra, Australia and Stuttgard, Germany.
– The company closed a USD$9.7m seed funding.
– The round was co-led by the QxBranch founders’ and Main Sequence investment consortium with participation from CP Ventures, Investible, Jelix Ventures, MA Financial (formerly Moelis Australia) Growth Ventures Fund, R3I Ventures, and Ultratech Capital Partners.
– The new funding will be used to hire for 20 roles including VP of Engineering and scientists, physicists, software engineers and control engineers.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Main Sequence Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: